Fundamental analysis by 💠 سامان تحلیل 💠 about Stock دسانکو on 17 hour ago

💊 Deal 2 billion Rials #Danco with Food and Drug Administration مان #Deano has signed a contract worth 1.5 million riyals on the sales of Dr. Mehdi Pir Poirsalihi on 1/8/11 to the Food and Drug Administration to sell the country's drugs. According to the provisions of the contract, 5 % of the amount was settled as a prepayment and the remainder proportional to the stage delivery of the goods. It is estimated that this cooperation will create nearly 2 % for the impurities margin. Because of its high figure, the contract could significantly strengthen the Danco cash flow in the second half of the fiscal year and improve the company's operating profit margin. It makes it easier to get a 5 % pre -payment of working capital management and reduces the risk of liquidity, especially as contract products include high -risk and low -risk drugs. However, reliance on payments on a state -of -the -art settlement increases the likelihood of delay in receiving claims, and grammatical pricing policies or exchange rate changes can reduce the anticipated profit margin. Also, reliance on a large contract may cause income fluctuations if they do not extend. On the other hand, despite the importance of the contract for the company's financial statements, its impact on stock prices was likely to be short -term, and investors should consider other variables of the pharmaceutical market and currency policies in decision making. مان #Stock Exchange #Industry_Do -Document #Contracting_Dends #Analysis_Berne #Market_Set #Themia ╭━━ 🚀 @samantahlil members ╰━━ 💠 In the course of analysis, awareness and transformation ... 💠 💠 💠